Cargando…

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure

The clinical utility of plasma natriuretic peptide concentrations in dogs with right-sided congestive heart failure (CHF) remains unclear. We investigated whether plasma levels of atrial natriuretic peptide (ANP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) are useful for assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	KANNO, Nobuyuki, HORI, Yasutomo, HIDAKA, Yuichi, CHIKAZAWA, Seishiro, KANAI, Kazutaka, HOSHI, Fumio, ITOH, Naoyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Veterinary Science 2015
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873841/ https://www.ncbi.nlm.nih.gov/pubmed/26607133 http://dx.doi.org/10.1292/jvms.15-0435

Ejemplares similares

Indirect arterial blood pressure measurement in healthy anesthetized cats using a device that combines oscillometry with photoplethysmography
por: HEISHIMA, Yasuhiro, et al.
Publicado: (2016)

Hyperferritinemia is associated with short survival time in dogs with multicentric lymphoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2015)

Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

Erythrophagocytosis Enhances Heme-Dependent Cytotoxicity of Antimalarial Drugs in Canine Histiocytic Sarcoma Cell Line DH82
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

Plasma N-Terminal Pro B-Type Natriuretic Peptide Concentrations in Dogs with Pulmonic Stenosis
por: KOBAYASHI, Keiya, et al.
Publicado: (2014)

Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease
por: OGAWA, Mizuki, et al.
Publicado: (2021)

Change in Serum Ferritin Concentration in Experimentally Induced Anemia of Chronic Inflammation in Dogs
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

Repeated phlebotomies decrease body iron storage in adult dogs
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2017)

Factors Influencing Measurement of Serum Iron Concentration in Dogs: Diurnal Variation and Hyperferritinemia
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Prevalence of Giardia intestinalis and other zoonotic intestinal parasites in private household dogs of the Hachinohe area in Aomori prefecture, Japan in 1997, 2002 and 2007
por: Itoh, Naoyuki, et al.
Publicado: (2009)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Combined Use of Serum N-terminal Pro-B-Type Natriuretic Peptide and Glypican-6 in the Diagnosis of Heart Failure
por: Sağlam, Emre Cem, et al.
Publicado: (2023)

Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs
por: Ogawa, Mizuki, et al.
Publicado: (2023)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure
por: Chang, Huai-Ren, et al.
Publicado: (2013)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure
por: Hebl, Virginia, et al.
Publicado: (2012)

Great Tool or Gold Standard? B-Type Natriuretic Peptide and Congestive Heart Failure
por: Montez, Jeremy, et al.
Publicado: (2011)

A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008)

Natriuretic Peptides, Cardio-Oncology…
Publicado: (2023)

Vector synthesis high‐resolution electrocardiography, atrial natriuretic peptide and N‐terminal prohormone brain natriuretic peptide for estimation of cardiac load in pregnancy
por: Tanaka, Shino, et al.
Publicado: (2016)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
por: Cavalcante, Pâmela Nogueira, et al.
Publicado: (2023)

Hospitalization and medical cost of patients with elevated serum N-terminal pro-brain natriuretic peptide levels
por: Kitagawa, Toshiro, et al.
Publicado: (2018)

Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients
por: Wang, Ji-Hung, et al.
Publicado: (2013)

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
por: Goltsman, Ilia, et al.
Publicado: (2019)

Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure
por: Luo, Jing‐chao, et al.
Publicado: (2022)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Perioperative changes in plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide in patients undergoing coronary bypass surgery under cardiopulmonary bypass
por: Ciufu, M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_rdu5bkkqpbbsase0juc4r3svuv